Oral Recombinant Methioninase Overcomes Colorectal-cancer Liver Metastasis Resistance to the Combination of 5-Fluorouracil and Oxaliplatinum in a Patient-derived Orthotopic Xenograft Mouse Model-Reference-Cited by-同舟云学术

Oral Recombinant Methioninase Overcomes Colorectal-cancer Liver Metastasis Resistance to the Combination of 5-Fluorouracil and Oxaliplatinum in a Patient-derived Orthotopic Xenograft Mouse Model

Published:2019-09 Issue:9 Volume:39 Page:4667-4671
ISSN:0250-7005
Container-title:Anticancer Research
language:en
Short-container-title:Anticancer Res

Author:

OSHIRO HIROMICHI,TOME YASUNORI,KIYUNA TASUKU,YOON SANG NAM,LWIN THINZAR M.,HAN QINGHONG,TAN YUYING,MIYAKE KENTARO,HIGUCHI TAKASHI,SUGISAWA NORIHIKO,KATSUYA YUKI,PARK JUN HO,ZANG ZHIYING,RAZMJOOEI SAHAR,BOUVET MICHAEL,CLARY BRYAN,SINGH SHREE RAM,KANAYA FUMINORI,NISHIDA KOTARO,HOFFMAN ROBERT M.

Publisher

Anticancer Research USA Inc.

Subject

Cancer Research,Oncology,General Medicine

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical human and murine models of hepatocellular carcinoma (HCC);Clinics and Research in Hepatology and Gastroenterology;2024-08

2. The potential of methioninase for cancer treatment;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-07

3. DNA-Binding Agent Trabectedin Combined With Recombinant Methioninase Is Synergistic to Decrease Fibrosarcoma Cell Viability and Induce Nuclear Fragmentation But Not Synergistic on Normal Fibroblasts;Anticancer Research;2024-05-31

4. Extensive Synergy Between Recombinant Methioninase and Eribulin Against Fibrosarcoma Cells But Not Normal Fibroblasts;Anticancer Research;2024-02-29

5. Engineered Methioninase-Expressing Tumor-Targeting Salmonella Typhimurium A1-R Inhibits Syngeneic-Cancer Mouse Models by Depleting Tumor Methionine;2024